Blood Cell Imaging Analysis Using Mixed Coherent Light Signals

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing hematology analyzers require manual, highly skilled personnel for abnormal sample analysis due to the need for high magnification morphological assessment, which is not automated.

Innovation Solution

A device and method utilizing coherent and partially coherent light sources, optics, detectors, and machine learning algorithms to analyze blood cells using electromagnetic radiation wavelengths, enabling automated cell counting, sizing, and differentiation without high magnification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If flow cytometry is used to count cells through an aperture, then rapid measurement of cell count, size, and type is achieved, but manual analysis by highly skilled personnel is required when abnormalities are detected

Engineering Contradiction:
Improvecell measurement speedVSAvoidautomated abnormality analysis
Core Design Contradiction:
ProductivityVSExtent of automation

Solution Approach 1:

The patent combines flow cytometry with digital imaging technology, merging the rapid cell measurement capability with automated visual inspection. The system integrates a camera to capture images of cells as they pass through the aperture, allowing automated analysis of both normal and abnormal cells without requiring manual intervention.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent introduces digital imaging as an intermediary between flow cytometry detection and manual analysis. The imaging system captures visual data of cells, which is then processed by image recognition algorithms to identify abnormalities, serving as a mediator that automates the previously manual assessment process.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If manual staining and imaging at higher magnification is performed, then accurate identification of abnormal cells is achieved, but the process requires highly skilled personnel and increased time

Engineering Contradiction:
Improveabnormal cell identification accuracyVSAvoidmanual analysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent performs preliminary imaging of cells during the flow cytometry process itself, capturing images before any manual analysis is needed. This preliminary action allows the system to pre-identify potential abnormalities using automated image recognition, reducing the time required for subsequent manual verification and focusing expert analysis only on suspicious cases.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent replaces the mechanical process of manual staining and high-magnification microscopy with automated digital imaging and image processing algorithms. The system uses computer vision technology to automatically identify and characterize abnormal cells, substituting human expertise with automated computational analysis that operates faster and without fatigue.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Loss of information

If high magnification morphological assessment is used, then detailed cell structure analysis is achieved, but automation is not possible and skilled personnel are required

Engineering Contradiction:
Improvemorphological detail retentionVSAvoidoperation simplicity
Core Design Contradiction:
Loss of informationVSEase of operation

Solution Approach 1:

The patent transitions from traditional two-dimensional microscopy images to three-dimensional spatial information by capturing images at multiple focal planes as cells pass through the aperture. This dimensional approach allows automated analysis to reconstruct detailed morphological features while maintaining the ability to perform high-throughput automated processing, combining detail retention with operational simplicity.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Facilitates fast and reliable identification and counting of different blood cell types, including red blood cells, white blood cells, and platelets, with reduced reliance on manual intervention.

Implementation Method 1

one or more coherent light sources and one or more partially coherent light sources, wherein the light sources are collectively configured to emit a first wavelength of electromagnetic (EM) radiation and a second wavelength of EM radiation

Methodology Applied
Scientific EffectLight emission from coherent and partially coherent sources: Laser

Implementation Method 2

one or more optics positioned to receive light from the imaging chamber

Methodology Applied
Scientific EffectLight transmission through optics: Lens

Implementation Method 3

The one or more detectors are configured to detect (i) fluorescence emission

Methodology Applied
Scientific EffectFluorescence emission detection: Fluorescence

Implementation Method 4

The one or more detectors are configured to detect (ii) EM radiation backscatter from, and/or EM radiation transmission through, a plurality of blood cells

Methodology Applied
Scientific EffectElectromagnetic radiation backscatter: Scattering

Data Source

PatentUS12474269B1Device, method, and system for sample analysis
Publication Date: 2025.11.18 VITAL BIOSCIENCES INC
  • US12474269B1 patent drawing
  • US12474269B1 patent drawing
  • US12474269B1 patent drawing

AI summary

Methods and devices for analyzing a sample from a subject are provided. A device includes one or more coherent light sources and one or more partially coherent light sources. The light sources are configured to emit first and second wavelengths of electromagnetic radiation towards an imaging chamber configured to hold blood cells. The light sources are aligned to illuminate a single common area of the imaging chamber. The device includes optics positioned to receive light from the imaging chamber, and a detector in optical communication with the optics. The detector is configured to detect fluorescence emission and backscatter from blood cells when present in the imaging chamber. The device includes mixers/unmixers configured to replicate and mix first and second signals representative of the responses to the first and second wavelengths after interacting with the plurality of blood cells to generate spectro-spatial responses.